Skip to content

Healthy Age-dependent Reference Values for Microvascular Structure and Function

Assessing Age-dependent Reference Values for Microvascular Structure and Function in Healthy Participant Together With Macrovascular Function With Optical Coherence Tomography Angiography

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04897191
Enrollment
50
Registered
2021-05-21
Start date
2021-05-18
Completion date
2021-08-31
Last updated
2021-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Stiffness, Healthy Ageing, Microvascular Circulation, Vascular Endothelium

Brief summary

The greatest challenge in our ageing society are cardiovascular diseases such as stroke, heart attack, peripheral artery disease of the legs with non-healing wounds (ulcers), or diabetes. How healthy ageing affects the smallest blood vessels (microcirculation) and is not well understood. One reason for this is that no generally available medical instrument has the resolution to study the microcirculation. The recently developed optical coherence tomography angiography (OCTA), currently mainly used by eye doctors, is able to visualise the microcirculation. We have developed an automated software (OCTAVA) to determine metrics to characterise the microcirculation on the layers of density, diameter and tortuosity. In the current study we aim at providing reference values of these metrics in hands and feet of healthy people according to age together with macrovascular function in arms and legs.

Interventions

OTHERAge

Determination of age-dependence

Sponsors

University of Surrey
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy, 20-70 years, BMI 20-30 kg/m\^2

Exclusion criteria

Diabetes mellitus, symptoms of acute infection, cardiac arrhythmias, active malignancy, clinical signs or symptoms of cardiovascular disease (coronary artery disease, lower extremity artery disease, cerebrovascular disease): angina pectoris, dyspnea, palpitation, syncope, claudication, active vasoactive medication.

Design outcomes

Primary

MeasureTime frameDescription
Microvascular density1 day (One timepoint during single visit)Density of skin microvasculature of hand and foot with OCTA at rest and after 5 min distal occlusion
Microvascular diameter1 day (One timepoint during single visit)Diameter of skin microvasculature of hand and foot with OCTA at rest and after 5 min distal occlusion
Microvascular turtuosity1 day (One timepoint during single visit)Turtuosity of skin microvasculature of hand and foot with OCTA at rest and after 5 min distal occlusion

Secondary

MeasureTime frameDescription
Blood pressure1 day (One timepoint during single visit)Upper arm blood pressure and leg systolic blood pressure
Endothelial function1 day (One timepoint during single visit)Flow-mediated dilation of brachial and common femoral artery with ultrasound
Arterial stiffness1 day (One timepoint during single visit)Pulse wave velocity measured at upper arm (Arteriograph)

Countries

United Kingdom

Contacts

Primary ContactChristian Heiss, Prof.
c.heiss@surrey.ac.uk+441737231749
Backup ContactDanuta Sampson, Dr.
danuta.sampson@surrey.ac.uk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026